Fabian Hulpia
13PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Aug 26, 2025
Discovery of Gut-Restricted PRMT5 Inhibitors to Intercept Colorectal Cancer in Patients with Genetic Loss of Tumor Suppressor Adenomatous Polyposis Coli.Fabian Hulpia, Wim Schepens, Susan Lepri
|Nov 26, 2022
Phenotypic Evaluation of Nucleoside Analogues against <i>Trypanosoma cruzi</i> Infection: In Vitro and In Vivo Approaches.Ludmila F de A Fiuza, Denise G J Batista, Roberson D Girão
|Aug 26, 2022
Ex Vivo Feedback Control of Neurotransmission Using a Photocaged Adenosine A1 Receptor Agonist.Erine Craey, Fabian Hulpia, Jeroen Spanoghe
|Jan 21, 2022
A <i>Toxoplasma gondii</i> Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes.Gustavo D Campagnaro, Hamza A A Elati, Sofia Balaska
|Apr 30, 2021
4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in <i>Trypanosoma brucei</i>.Dorien Mabille, Camila Cardoso Santos, Rik Hendrickx
|Apr 15, 2021
6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy.Cai Lin, Ludmila Ferreira de Almeida Fiuza, Camila Cardoso Santos
Pageof 3
Frequent Collaborators
11 joint publications
Serge Van Calenbergh
4 joint publications
Harry P de Koning
3 joint publications
Guy Caljon
3 joint publications
Gustavo Daniel Campagnaro
2 joint publications
Christophe Stove
2 joint publications
Dorien Mabille
1 joint publications
Peter Blanckaert
1 joint publications
Annelies Cannaert
1 joint publications
Katleen Van Uytfanghe
1 joint publications
Isabel Roditi
